Posterior Reversible Encephalopathy Syndrome after a Variety of Combined Chemotherapies Containing Bevacizumab for Metastatic Colon Cancer
Author:
Affiliation:
1. Department of Neurology, Nagoya City West Medical Center, Japan
2. Department of Intestinal Surgery, Nagoya City West Medical Center, Japan
3. Department of Radiology, Nagoya City West Medical Center, Japan
Publisher
Japanese Society of Internal Medicine
Subject
General Medicine,Internal Medicine
Link
https://www.jstage.jst.go.jp/article/internalmedicine/57/16/57_0284-17/_pdf
Reference23 articles.
1. 1. Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiolology, and outstanding questions. Lancet Neurol 14: 914-925, 2015.
2. 2. Plavetić ND, Rakušic Z, Ozretić D, Simetić L, Krpan AM, Bišof V. Fatal outcome of posterior "reversible encephalopathy syndrome in metastatic colorectal carcinoma after irinotecan and fluropyrimidine chemotherapy regimen. World J Surg Oncol 12: 264, 2014.
3. 3. Ohira J, Mori N, Kajikawa S, et al. Posterior reversible encephalopathy syndrome with extensive deep white matter lesions including the temporal pole. Intern Med 55: 3529-3533, 2016.
4. 4. Sugimoto S, Yamamoto YL, Nagahiro S, Diksic M. Permeability change and brain tissue damage after intracarotid administration of cisplatin studied by double-tracer autoradiography in rats. J Neurooncol 24: 229-240, 1995.
5. 5. Giuseppe F, Todd AH, Judith MS, Lisa GH. Posterior reversible encephalopathy syndrome following chemotherapy with oxaliplatin and a fluoropyrimidine: a case report and literature review. Asia-Pacific J Clin Oncol 8: 115-122, 2012.
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Capecitabine-induced posterior reversible encephalopathy syndrome (PRES) in a patient with gastric adenocarcinoma;BMJ Case Reports;2023-11
2. Case report: PRES associated with fruquintinib in a patient with metastatic colon cancer;Neurological Sciences;2023-08-15
3. Posterior reversible encephalopathy syndrome after anlotinib treatment for small cell lung cancer: A case report and literature review;Frontiers in Pharmacology;2023-02-06
4. S-1＋Irinotecan＋Bevacizumab併用療法中に可逆性後頭葉白質脳症を発症した進行再発直腸癌の１例;JOURNAL OF THE JAPANESE ASSOCIATION OF RURAL MEDICINE;2023
5. Posterior Reversible Encephalopathy Syndrome: A Review of the Literature;Internal Medicine;2022-01-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3